KKK. G. Kurochkina

K. G. Kurochkina

*This is an algorithmically generated author record based on publicly available information.

K. G. Kurochkina has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Tamara S. Novik

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution "Federal Scientific Centre VIEV

    5 shared publications
  • Elena I. Koveshnikova

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution "Federal Scientific Centre VIEV

    4 shared publications
  • Gella V. Konovalova

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution "Federal Scientific Centre VIEV"; The Russian State Center for Animal Feed and Drug Standardization and Quality (VGNKI)

    2 shared publications
  • Ivan A. Arkhipov

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV” (VNIIP – FSC VIEV)

    2 shared publications
  • M. B. Musaev

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV” (VNIIP – FSC VIEV)

    2 shared publications
  • S. I. Chukina

    All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant — a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV

    2 shared publications

Latest Publications

  • Open Access

    Study on the subchronic toxicity of an antiparasitic combined drug from the group of avermectins and pyrethroids on rats

    by V. V. Tokar, M. B. Musaev, T. S. Novik, K. G. Kurochkina, E. I. Koveshnikova, O. I. Tikhomirova, R. K. Alikebedov

    The purpose of the research is to evaluate the subchronic toxicity in rats of a prototype antiparasitic combined drug from the group of avermectins and pyrethroids conditionally named as CA-18. Materials and methods. The subchronic toxicity was studied on mature outbred male rats to whom the test drug CA-18 was applied epicutaneously at doses of 1,000 and 500 mg/kg for 7 days. The above doses were based on vivisection results and were 1/5 and 1/10 of LD 50 that was 5,000 mg/kg. During the drug application period, the animals' condition and behavior, and local reactions were monitored. Body weight gain dynamics, organ mass coefficients, and biochemical and hematological parameters were determined. Macroscopic examination was performed for the organs, cavities, and skin to which the drug was applied. This experiment included a 10-day aftereffect period when the same parameters as above were determined. Statistical data analysis was performed using the analysis of variance, with a two-sided Student's t-test for a simple comparison of the means. Differences were determined at the significance level of 0.05 . Results and discussion. No animal deaths were observed during the study. The rats consistently gained weight with no signs of intoxication observed in either the drug administration or the aftereffect period. Macroscopic examination of organs, cavities, and skin revealed no pathology. The liver, kidney, heart, and spleen mass coefficients did not show statistically significant changes. There were no changes in biochemical or hematological parameters. No lethal or toxic dose could be determined in this experiment; all doses tested were subtoxic. CA-18 was well tolerated in the subchronic toxicity study.

  • Open Access

    Testing new antiparasitic combination drugs based on avermectins and pyrethroids against endo- and ectoparasitosis of cattle

    by M. B. Musaev, В. В. Токарь, T. S. Novik, K. G. Kurochkina, O. I. Tikhomirova, R. K. Alikebedov

    The purpose of the research is to test two new experimental samples of antiparasitic avermectin and pyrethroid combination drugs (CA-7 and KC-3) in a liquid form for dermal application against ixodid ticks and gastrointestinal nematodes of cattle.Materials and methods. The studies were conducted on 137 animals (cows, bulls, and heifers) of the Simmental breed. Of these, 64 animals most infected with ticks and gastrointestinal nematodes were selected for titration of therapeutic doses and divided into 8 experimental groups of 8 animals each. Drug samples were applied epicutaneously in a range of doses that allowed selecting necessary volumes to obtain the maximum therapeutic effect. To compare the results of the drugs against ticks, the remaining 73 animals were treated in parallel with a commercial insectoacaricidal drug widely used at the experiment site. Faecal samples were collected from the test animals before and on day 7 after application for diagnostics. A coproovoscopic examination was conducted using the Fülleborn flotation method with a saturated sodium chloride solution. The average number of gastrointestinal Strongylata eggs in 1 g of faeces was calculated using a counting chamber. After drug applications, the general condition and local reactions were observed, and the tick and gadfly larvae infection of the animals was recorded. A "critical test" was used to process the obtained data and evaluate the drug efficacy against ixodid ticks and nematodes.Results and discussion. The extensive effectiveness (EE) of CA-7 against ixodid ticks was obtained at doses of 0.2; 0.3; 0.4; and 0.5 mg/kg for avermectin C (active substance) or 4.0; 6.0; 8.0 and 10.0 mL/100 of the body weight for the drug, respectively: 0; 37.5; 62.5 and 87.5% with an average decrease in ticks per animal of 33.0; 98.4; 99.4 and 99.9%. CA-7 against gastrointestinal nematodes of cattle in the same doses showed, on average, a decrease in the number of nematode eggs in 1 g of feces, respectively: 65.1; 86.7; 92.4 and 100% with the EE of 50.0; 75.0; 87.5 and 100%. KC-3 when used in the same doses showed the EE against ixodid ticks equal to 0; 50.0; 75.0 and 87.5%, respectively, with a decrease in the number of ticks per animal of 84.6; 88.6; 98.9 and 99.1% and a decrease, on average, in the number of Strongylata eggs in 1 g of feces, respectively, by 73.4; 84.6; 91.5 and 93.8% with the EE 37.5; 75.0; 87.5 and 87.5%. Both drugs showed 100% efficacy against hypoderma at a maximum dose of 0.5 mg/kg of the body weight for avermectin C when applied topically.

  • Open Access

    Investigation of Trichinella spiralis protein extract on humoral and cellular immunity in mice

    by G. V. Konovalova, K. G. Kurochkina

    Relevance. The present experiment was performed on 113 CBA × C57BL/6 mice males. T. spiralis extract was administered to mice intraperitoneally once and six times at the dose level of 100 mkg/animal; Trichinella larvae were administered per os at the rate of 10 larvae per 1 g. The immunotropic effect was evaluated on the 8th and 21st days after a single and last six-fold administration of the extract. The effects on humoral immunity were determined in the hemagglutination reaction; cellular immunity was assessed in delayed-type hypersensitivity (DTH) reaction to sheep erythrocytes. In one variant of the experiment (on the 8th day after a single and last six-fold administration of the protein extract), a histological examination of samples of organs (spleen, thymus, lymph nodes, liver) involved in the functioning of the immune system was performed.Results. According to the results of comprehensive assessment of humoral and cellular immunity, using specific indices and microscopic analysis data, it can be concluded that Trichinella somatic extract showed immunosuppressive effect with the most pronounced effect on cellular immunity. It is possible that the suppression of cellular immune response is associated with cytotoxic effect of T. spiralis extract on cells, including those of immune system.

  • Investigation of general toxic effects of Relatox in comparison with Dysport

    by T.S. Novik, E.I. Koveshnikova, K.G. Kurochkina, S.I. Chukina

    Objective. To evaluate the toxic effects of the agent Relatox on mature outbred rats and mice in an acute experiment in comparison with the registered analogue Dysport. Material and methods. Based on the aim of experiment, the acute toxic effects of Relatox and Dysport were assessed on two animal species: rats and mice at intraperitoneal and intramuscular administration at dose levels that made it possible to calculate the toxicological parameter values (initially 10—150 U/kg with subsequent usage of additional doses 20 U/kg to 300 U/kg depending on the agent and route of administration). The LD50 values and other acute toxic parameters were calculated using probit analysis. Results. The manifested intoxication picture was observed following administration of both agents, in which neurological symptoms specific to botulinum toxin came to the fore: muscle paresis and local paralysis, which were the result of the mode of therapeutic action of the toxin. The observed picture of intoxication, monitoring of the dynamics of body weight gains, as well as data of macroscopic analysis of organs and tissues indicate a complete analogy of animal responses to both agents administration. However, the mortality rates of animals differed when administered at different doses as well as the established LD50 values of Relatox and Dysport. Conclusions. Both agents were more toxic when administered intraperitoneally than intramuscularly. Species or gender sensitivities were no detected for both agents. LD50 values of Relatox and Dysport established based on the results of an acute experiment, should be considered taking into account the differences (approximately 2.5—3-folds) in the specific activity of these agents.


  • Open Access

    Antiproliferative activity in vitro of Trichinella spiralis larval extracts depending on the infection stage following experimental infection of rats

    by G. V. Konovalova, E. I. Koveshnikova, M. M. Kаganova, E. D. Nikolskaya, N. G. Yabbarov, K. G. Kurochkina

    Relevance.The aim is evaluation in vitro antiproliferative activity of T. spiralis larvae extracts obtained from experimentally infected rats, depending on the duration of infection.Methods. The experiment was carried out on outbred male rats infected with T. spiralis larvae at the rate of 10 larvae per 1 g of body weight. The antiproliferative activity of larval extracts obtained 40 days, 3 and 12 months after infection was determined on tumor cells of the A549 line (human lung carcinoma) using an MTT test during cultivation for 24, 48 and 72 hours in concentrations from 32 to 1000 micrograms/ml. Antiproliferative activity was expressed as % inhibition and IC50.Results. There was direct dependence of Trichinella extract antiproliferative effects on time of cultivation with A549 cells and protein concentration in extracts. At all stages of invasion, the antiproliferative activity of the extract increased from 24 to 72 hours. at a protein concentration of 250 to 1000 mcg/ml. The extract antiproliferative activity expressed in tumor cell % inhibition and IC50 increased from day 40 to month 12. The most intense dynamics was observed between day 40 and month 3. The possible reason of enhancement in extract antiproliferative effect at months 3 and 12 is alteration in quantitative and qualitative composition of proteins comprised the extracts.


  • Open Access

    Effects of Trichinella spiralis and Echinococcus multilocularis extracts after single and multiple injections on mitosis and hematological and biochemical parameters of mice

    by T. S. Novik, E. I. Koveshnikova, S. I. Chukina, L. A. Napisanova, O. N. Andreyanov, I. A. Arkhipov, K. G. Kurochkina

    The purpose of the research is to study effects of Trichinella spiralis and Echinococcus multilocularis extracts on mitosis in a bone marrow cell population, and on hematological and biochemical blood parameters of mice after single and multiple intraperitoneal injections.Materials and methods. The experiment was conducted on outbred male mice. The T. spiralis and E. multilocularis extracts were administered intraperitoneally once or multiple times daily for 10 days at a dose of 80 μg/mouse. Bone marrow cell isolation, microscopic preparations, mitotic index and individual stage determination were made as described in the literature (Ford C. E., Hamerton J. L., 1956). The mouse main peripheral blood parameters were determined with a MicroCC-20 Plus hematological analyzer, and the leucogram was determined by a conventional method. Biochemical blood parameters of the mice were determined with a Clima MC-15 analyzer.Results and discussion. The T. spiralis and E. multilocularis extracts after a single intraperitoneal injection at a dose of 80 μg/ mouse had a pronounced negative effect on the mouse bone marrow cell mitosis with the cell division terminated in the metaphase and a decreased proportion of other mitosis stages. Characteristics were detected of the effects made by the T. spiralis and E. multilocularis extracts on the mouse bone marrow cell mitosis after multiple administration for 10 days. In the reinjection mode of the test extracts to the mice, hematological and biochemical parameters did not change.


  • Open Access

    Evaluation of supramolecular complex of fenbendazole effect on embryonic development

    by A. I. Varlamova, N. B. Emelyanova, I. A. Arkhipov, T. S. Novik, K. G. Kurochkina, V. E. Abramov

    The purpose of the research is to study the embryotropic effect of supramolecular complex of fenbendazole (SMСF).Materials and methods. The experiment to assess the embryotropic properties of SMCF was carried out on 40 white female and 20 male rats in accordance with the Guidelines for the experimental (preclinical) study of new pharmacological substances. Pregnant female rats were divided into 3 experimental and one control groups. SMCF was administered intragastrically on the 1–6 days of embryogenesis (group 1); on the 7–14 days (group 2) and on the 15–19 days (group 3) in three times therapeutic dose – 6,0 mg/kg of active substance. The animals of the control group received saline from the first to the 19th days of pregnancy. Rats were euthanized on the 20th day of pregnancy. The uterus with fetuses was removed after laparotomy, the number of corpora lutea, implantation sites, the number of living, dead and resorbed fetuses were recorded, the weight and diameter of the placenta were determined. The embryos were examined, weighed, the craniocaudal sizes were determined, the levels of total embryonic, preimplantation and postimplantation embryo death were calculated. The fetuses were examined for abnormalities of internal organs and changes in the skeletal system according to the methods of J. G. Wilson (1965) and A. B. Dawson (1926), modified in the department of embryology of the IEM of the USSR Academy of Medical Sciences.Results and discussion. As a result, SMCF does not induce toxic effects on the fetus: mortality rates, size and weight of embryos were at the level of the control group in a threefold therapeutic dose 6,0 mg/kg at intragastric administration on the 1–6; 7–14 and 15–19 days of pregnancy. SMCF did not cause external and internal malformations.